Kuhen, Kelli L <br/><br/>
KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Sep 2014 
 - 5060-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.02727-13  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antimalarials--pharmacology<br/>Imidazoles--pharmacology<br/>Inhibitory Concentration 50<br/>Malaria, Falciparum--drug therapy<br/>Mice<br/>Mice, Inbred ICR<br/>Piperazines--pharmacology<br/>Plasmodium falciparum--drug effects<br/>Sporozoites--drug effects